Skip Page Header

Home > EU drug markets report 2019.

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2019) EU drug markets report 2019. Luxembourg: Publications Office of the European Union. 260 p.

[img]
Preview
PDF (EU drug markets report 2019)
35MB
[img]
Preview
PDF (Highlights from the EU Drug Markets Report for policy and practice 2019) - Supplemental Material
14MB
[img]
Preview
PDF (Estimating the size of the main illicit retail drug markets in Europe: update, 2p.) - Supplemental Material
315kB
[img]
Preview
PDF (Using open-source information to improve the European drug monitoring system) - Supplemental Material
6MB

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in this report spans numerous topics such as the links between drugs and other crimes, the licit economy and society more generally as well as the processes and players involved in the trade, from production and trafficking to distribution. Taking an evidence-based approach, the report reviews the markets for heroin, cocaine, cannabis, amphetamine, methamphetamine, MDMA and new psychoactive substances. It also provides action points to inform policy development at EU and national level. This publication is an essential reference for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.


Repository Staff Only: item control page